Live Breaking News & Updates on Aluwani museisi

Stay informed with the latest breaking news from Aluwani museisi on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Aluwani museisi and stay connected to the pulse of your community

NEPAD

When NEPAD (New Partnership for Africa's Development) was adopted some 20 years ago by the African Union in 2002, it was a time of extraordinary African

South-africa , United-states , Nigeria , Egypt , Senegal , Algeria , South-africans , American , Aluwani-museisi , Seara-mkhabela , Mahomed-jahed , Yolisa-kani

Vaccine trial leaders dismiss top adviser's claims th...

The chairperson of the ministerial advisory committee (MAC) on Covid-19 vaccines, Professor Barry Schoub, has claimed researchers missed the opportunity to leverage the country’s participation in clinical trials to secure access to vaccines once they became available.
Schoub made the comments during an interview with Judge Dennis Davis, published on Wednesday, while the state faces criticism for failing to conclude any bilateral agreements with vaccine manufacturers.

He said the country’s ability to access vaccines went wrong when leaders of clinical trials did not insist that manufacturers are contractually obliged to supply their products to South Africa.
“It should have been a commitment as part of their arrangement. We didn’t do that. We could have had Johnson & Johnson. We could have had AstraZeneca and to some extent also Pfizer because they were trialled here,” said Schoub.

South-africa , South-africans , Shabir-madhi , Aluwani-museisi , Zweli-mkhize , Linda-gail-bekker , Glenda-gray , Barry-schoub , Dennis-davis , Blade-nzimande , Infectious-diseases-analytics-research-unit , Pfizer